drug_name,side_effect,side_effect_2,side_effect_3,side_effect_4,disease_name,drug_category
cetuximab,somnolence,cough,renal failure,carcinoma,Adenocarcinoma,Antineoplastic agents
cetuximab,somnolence,cough,renal failure,carcinoma,Complementary component deficiency,Antineoplastic agents
cetuximab,somnolence,cough,renal failure,carcinoma,"IgG receptor I, phagocytic, familial deficiency of",Antineoplastic agents
cetuximab,somnolence,cough,renal failure,carcinoma,Lupus erythematosus,Antineoplastic agents
cetuximab,somnolence,cough,renal failure,carcinoma,Lymphoma,Antineoplastic agents
cetuximab,somnolence,cough,renal failure,carcinoma,Neutropenia,Antineoplastic agents
cetuximab,somnolence,cough,renal failure,carcinoma,Nonsmall cell lung cancer,Antineoplastic agents
cetuximab,somnolence,cough,renal failure,carcinoma,Viral infection,Antineoplastic agents
cetuximab,somnolence,cough,renal failure,carcinoma,"Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980",Antineoplastic agents
cetuximab,somnolence,cough,renal failure,carcinoma,"C1q deficiency, type A",Antineoplastic agents
cetuximab,somnolence,cough,renal failure,carcinoma,"C1q deficiency, type B",Antineoplastic agents
cetuximab,somnolence,cough,renal failure,carcinoma,"C1s deficiency, isolated",Antineoplastic agents
cetuximab,somnolence,cough,renal failure,carcinoma,"Lupus nephritis, susceptibility to",Antineoplastic agents
cetuximab,somnolence,cough,renal failure,carcinoma,"Lymphoma, progression of",Antineoplastic agents
cetuximab,somnolence,cough,renal failure,carcinoma,"Neutropenia, alloimmune neonatal",Antineoplastic agents
cetuximab,somnolence,cough,renal failure,carcinoma,"Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980",Antineoplastic agents
cetuximab,somnolence,cough,renal failure,carcinoma,"Viral infections, recurrent",Antineoplastic agents
denileukin diftitox,dizziness,pain,dehydration,vasodilatation,"Interleukin-2 receptor, alpha chain, deficiency of",Antineoplastic agents
denileukin diftitox,dizziness,pain,dehydration,vasodilatation,Severe combined immunodeficiency,Antineoplastic agents
denileukin diftitox,dizziness,pain,dehydration,vasodilatation,Combined immunodeficiency,Antineoplastic agents
denileukin diftitox,dizziness,pain,dehydration,vasodilatation,"Combined immunodeficiency, X-linked, moderate, 312863",Antineoplastic agents
denileukin diftitox,dizziness,pain,dehydration,vasodilatation,"Severe combined immunodeficiency, X-linked, 300400",Antineoplastic agents
etanercept,dizziness,nausea,melanoma,vasodilatation,Asthma,Antirheumatic agents
etanercept,dizziness,nausea,melanoma,vasodilatation,Asthma,Immunomodulatory agents
etanercept,dizziness,nausea,melanoma,vasodilatation,Complementary component deficiency,Antirheumatic agents
etanercept,dizziness,nausea,melanoma,vasodilatation,Complementary component deficiency,Immunomodulatory agents
etanercept,dizziness,nausea,melanoma,vasodilatation,Dementia,Antirheumatic agents
etanercept,dizziness,nausea,melanoma,vasodilatation,Dementia,Immunomodulatory agents
etanercept,dizziness,nausea,melanoma,vasodilatation,"IgG receptor I, phagocytic, familial deficiency of",Antirheumatic agents
etanercept,dizziness,nausea,melanoma,vasodilatation,"IgG receptor I, phagocytic, familial deficiency of",Immunomodulatory agents
etanercept,dizziness,nausea,melanoma,vasodilatation,Lupus erythematosus,Antirheumatic agents
etanercept,dizziness,nausea,melanoma,vasodilatation,Lupus erythematosus,Immunomodulatory agents
etanercept,dizziness,nausea,melanoma,vasodilatation,Lymphoma,Antirheumatic agents
etanercept,dizziness,nausea,melanoma,vasodilatation,Lymphoma,Immunomodulatory agents
etanercept,dizziness,nausea,melanoma,vasodilatation,Malaria,Antirheumatic agents
etanercept,dizziness,nausea,melanoma,vasodilatation,Malaria,Immunomodulatory agents
etanercept,dizziness,nausea,melanoma,vasodilatation,Migraine,Antirheumatic agents
etanercept,dizziness,nausea,melanoma,vasodilatation,Migraine,Immunomodulatory agents
etanercept,dizziness,nausea,melanoma,vasodilatation,Myocardial infarction,Antirheumatic agents
etanercept,dizziness,nausea,melanoma,vasodilatation,Myocardial infarction,Immunomodulatory agents
etanercept,dizziness,nausea,melanoma,vasodilatation,Neutropenia,Antirheumatic agents
etanercept,dizziness,nausea,melanoma,vasodilatation,Neutropenia,Immunomodulatory agents
etanercept,dizziness,nausea,melanoma,vasodilatation,Sepsis,Antirheumatic agents
etanercept,dizziness,nausea,melanoma,vasodilatation,Sepsis,Immunomodulatory agents
etanercept,dizziness,nausea,melanoma,vasodilatation,Viral infection,Antirheumatic agents
etanercept,dizziness,nausea,melanoma,vasodilatation,Viral infection,Immunomodulatory agents
etanercept,dizziness,nausea,melanoma,vasodilatation,"Asthma, susceptibility to, 600807",Antirheumatic agents
etanercept,dizziness,nausea,melanoma,vasodilatation,"Asthma, susceptibility to, 600807",Immunomodulatory agents
etanercept,dizziness,nausea,melanoma,vasodilatation,"C1q deficiency, type A",Antirheumatic agents
etanercept,dizziness,nausea,melanoma,vasodilatation,"C1q deficiency, type A",Immunomodulatory agents
etanercept,dizziness,nausea,melanoma,vasodilatation,"C1q deficiency, type B",Antirheumatic agents
etanercept,dizziness,nausea,melanoma,vasodilatation,"C1q deficiency, type B",Immunomodulatory agents
etanercept,dizziness,nausea,melanoma,vasodilatation,"C1s deficiency, isolated",Antirheumatic agents
etanercept,dizziness,nausea,melanoma,vasodilatation,"C1s deficiency, isolated",Immunomodulatory agents
etanercept,dizziness,nausea,melanoma,vasodilatation,"Dementia, vascular, susceptibility to",Antirheumatic agents
etanercept,dizziness,nausea,melanoma,vasodilatation,"Dementia, vascular, susceptibility to",Immunomodulatory agents
etanercept,dizziness,nausea,melanoma,vasodilatation,"Lupus nephritis, susceptibility to",Antirheumatic agents
etanercept,dizziness,nausea,melanoma,vasodilatation,"Lupus nephritis, susceptibility to",Immunomodulatory agents
etanercept,dizziness,nausea,melanoma,vasodilatation,"Lymphoma, progression of",Antirheumatic agents
etanercept,dizziness,nausea,melanoma,vasodilatation,"Lymphoma, progression of",Immunomodulatory agents
etanercept,dizziness,nausea,melanoma,vasodilatation,"Malaria, cerebral, susceptibility to",Antirheumatic agents
etanercept,dizziness,nausea,melanoma,vasodilatation,"Malaria, cerebral, susceptibility to",Immunomodulatory agents
etanercept,dizziness,nausea,melanoma,vasodilatation,"Migraine without aura, susceptibility to, 157300",Antirheumatic agents
etanercept,dizziness,nausea,melanoma,vasodilatation,"Migraine without aura, susceptibility to, 157300",Immunomodulatory agents
etanercept,dizziness,nausea,melanoma,vasodilatation,"Myocardial infarction, susceptibility to",Antirheumatic agents
etanercept,dizziness,nausea,melanoma,vasodilatation,"Myocardial infarction, susceptibility to",Immunomodulatory agents
etanercept,dizziness,nausea,melanoma,vasodilatation,"Neutropenia, alloimmune neonatal",Antirheumatic agents
etanercept,dizziness,nausea,melanoma,vasodilatation,"Neutropenia, alloimmune neonatal",Immunomodulatory agents
etanercept,dizziness,nausea,melanoma,vasodilatation,"Septic shock, susceptibility to",Antirheumatic agents
etanercept,dizziness,nausea,melanoma,vasodilatation,"Septic shock, susceptibility to",Immunomodulatory agents
etanercept,dizziness,nausea,melanoma,vasodilatation,"Viral infections, recurrent",Antirheumatic agents
etanercept,dizziness,nausea,melanoma,vasodilatation,"Viral infections, recurrent",Immunomodulatory agents
urokinase,back pain,nausea,melanoma,vasodilatation,Alzheimer disease,Thrombolytic agents
urokinase,back pain,nausea,melanoma,vasodilatation,"Conjunctivitis, ligneous",Thrombolytic agents
urokinase,back pain,nausea,melanoma,vasodilatation,Plasminogen deficiency,Thrombolytic agents
urokinase,back pain,nausea,melanoma,vasodilatation,"Alzheimer disease, late-onset, susceptibility to, 104300",Thrombolytic agents
urokinase,back pain,nausea,melanoma,vasodilatation,"Conjunctivitis, ligneous, 217090",Thrombolytic agents
urokinase,back pain,nausea,melanoma,vasodilatation,Plasminogen Tochigi disease,Thrombolytic agents
abciximab,back pain,nausea,melanoma,vasodilatation,Complementary component deficiency,Anticoagulants
abciximab,back pain,nausea,melanoma,vasodilatation,Complementary component deficiency,Antiplatelet agents
abciximab,back pain,nausea,melanoma,vasodilatation,Glanzmann thrombasthenia,Anticoagulants
abciximab,back pain,nausea,melanoma,vasodilatation,Glanzmann thrombasthenia,Antiplatelet agents
abciximab,back pain,nausea,melanoma,vasodilatation,"IgG receptor I, phagocytic, familial deficiency of",Anticoagulants
abciximab,back pain,nausea,melanoma,vasodilatation,"IgG receptor I, phagocytic, familial deficiency of",Antiplatelet agents
abciximab,back pain,nausea,melanoma,vasodilatation,Lupus erythematosus,Anticoagulants
abciximab,back pain,nausea,melanoma,vasodilatation,Lupus erythematosus,Antiplatelet agents
abciximab,back pain,nausea,melanoma,vasodilatation,Lymphoma,Anticoagulants
abciximab,back pain,nausea,melanoma,vasodilatation,Lymphoma,Antiplatelet agents
abciximab,back pain,nausea,melanoma,vasodilatation,Neutropenia,Anticoagulants
abciximab,back pain,nausea,melanoma,vasodilatation,Neutropenia,Antiplatelet agents
abciximab,back pain,nausea,melanoma,vasodilatation,Viral infection,Anticoagulants
abciximab,back pain,nausea,melanoma,vasodilatation,Viral infection,Antiplatelet agents
abciximab,back pain,nausea,melanoma,vasodilatation,"C1q deficiency, type A",Anticoagulants
abciximab,back pain,nausea,melanoma,vasodilatation,"C1q deficiency, type A",Antiplatelet agents
abciximab,back pain,nausea,melanoma,vasodilatation,"C1q deficiency, type B",Anticoagulants
abciximab,back pain,nausea,melanoma,vasodilatation,"C1q deficiency, type B",Antiplatelet agents
abciximab,back pain,nausea,melanoma,vasodilatation,"C1s deficiency, isolated",Anticoagulants
abciximab,back pain,nausea,melanoma,vasodilatation,"C1s deficiency, isolated",Antiplatelet agents
abciximab,back pain,nausea,melanoma,vasodilatation,"Glanzmann thrombasthenia, type B",Anticoagulants
abciximab,back pain,nausea,melanoma,vasodilatation,"Glanzmann thrombasthenia, type B",Antiplatelet agents
hydrocortisone,back pain,nausea,melanoma,vasodilatation,Asthma,Anti-inflammatory agents
hydrocortisone,back pain,nausea,melanoma,vasodilatation,Atherosclerosis,Anti-inflammatory agents
hydrocortisone,back pain,nausea,melanoma,vasodilatation,Cortisol resistance,Anti-inflammatory agents
hydrocortisone,back pain,nausea,melanoma,vasodilatation,Malaria,Anti-inflammatory agents
hydrocortisone,back pain,nausea,melanoma,vasodilatation,Obesity,Anti-inflammatory agents
hydrocortisone,back pain,nausea,melanoma,vasodilatation,"Asthma, dimished response to antileukotriene treatment in, 600807",Anti-inflammatory agents
hydrocortisone,back pain,nausea,melanoma,vasodilatation,"Atherosclerosis, susceptibility to",Anti-inflammatory agents
hydrocortisone,back pain,nausea,melanoma,vasodilatation,"Malaria, resistance to, 248310",Anti-inflammatory agents
hydrocortisone,back pain,nausea,melanoma,vasodilatation,"Obesity, adrenal insufficiency, and red hair",Anti-inflammatory agents
